Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05807646 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reduced Dissemination of Tumor Cells With Primary Ligation of the Inferior Mesenteric Vein in Rectal Cancer Patients.

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 15, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jan 2024 to Jan 2025v6
  2. Primary completion date: Dec 2024 to Dec 2025
    • Study completion date: Dec 2027 to Dec 2028
    • Start date: Dec 2023 to Jan 2024
    v5
  3. Enrollment target: 134 to 268
    • Eligibility criteria expanded, about 1 word
    v4
  4. Eligibility criteria shortened, about 3 wordsv3
  5. Secondary endpoints revised (10)
    • Study description revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Effect of ligation sequence of the inferior mesenteric artery and vein on circulating tumor cells and survival in laparoscopic rectal cancer surgery: a prospective, multicenter, randomized controlled study (ARVECTS)
Trial Details
NCT Number NCT05807646
Lead Sponsor Sichuan Cancer Hospital and Research Institute
Collaborators: Sichuan Provincial People's Hospital, The Second People's Hospital of Chengdu
Conditions
(from sponsor)		 Rectal Cancer
Related terms Rectal Neoplasms
Enrollment 268 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov